Your browser doesn't support javascript.
loading
Ginsenoside compound K reduces the progression of Huntington's disease via the inhibition of oxidative stress and overactivation of the ATM/AMPK pathway.
Hua, Kuo-Feng; Chao, A-Ching; Lin, Ting-Yu; Chen, Wan-Tze; Lee, Yu-Chieh; Hsu, Wan-Han; Lee, Sheau-Long; Wang, Hsin-Min; Yang, Ding-I; Ju, Tz-Chuen.
Afiliación
  • Hua KF; Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
  • Chao AC; Department of Biotechnology and Animal Science, National Ilan University, Ilan, Taiwan.
  • Lin TY; Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, Taiwan.
  • Chen WT; Department of Neurology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
  • Lee YC; Department of Neurology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Hsu WH; Department of Animal Science and Biotechnology, Tunghai University, Taichung, Taiwan.
  • Lee SL; Institute of Brain Science and Brain Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Wang HM; Wellhead Biological Technology Corp., Taoyuan, Taiwan.
  • Yang DI; Wellhead Biological Technology Corp., Taoyuan, Taiwan.
  • Ju TC; Wellhead Biological Technology Corp., Taoyuan, Taiwan.
J Ginseng Res ; 46(4): 572-584, 2022 Jul.
Article en En | MEDLINE | ID: mdl-35818427
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: J Ginseng Res Año: 2022 Tipo del documento: Article País de afiliación: Taiwán
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: J Ginseng Res Año: 2022 Tipo del documento: Article País de afiliación: Taiwán